Crimsonox Capital
Asia, Central Region, Singapore, Singapore'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Description
Crimsonox Capital
Investor Profile
Crimsonox Capital has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series D, Series C rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Therapeutics, Artificial Intelligence (AI), Machine Learning.
- Led 1 rounds in the past year.
Stage Focus
- Series B (33%)
- Series D (33%)
- Series C (33%)
Country Focus
- United States (100%)
Industry Focus
- Therapeutics
- Artificial Intelligence (Ai)
- Machine Learning
- Saas
- Biotechnology
- Mhealth
- Pharmaceutical
- Software
- Health Care
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.